Janus Henderson Group plc 13D and 13G filings for Forte Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-14 11:46 am Unchanged | 2025-06-30 | 13G | Forte Biosciences, Inc. FBRX | JANUS HENDERSON GROUP PLC JHG | 657,509 9.900% | 0 (Unchanged) | Filing |
| 2025-05-14 12:49 pm Sale | 2025-03-31 | 13G | Forte Biosciences, Inc. FBRX | JANUS HENDERSON GROUP PLC JHG | 657,509 9.900% | -33,234 (-4.81%) | Filing |
| 2025-02-14 11:25 am Purchase | 2024-12-31 | 13G | Forte Biosciences, Inc. FBRX | JANUS HENDERSON GROUP PLC JHG | 690,743 10.000% | 690,743 (New Position) | Filing |